Pro Medicus shares close in on record high amid massive contract win

Pro Medicus Limited (ASX: PME) shares are starting the week positively. In morning trade, the ASX 200 tech stock is …

| More on:
A young man punches the air in delight as he reacts to great news on his mobile phone.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Pro Medicus Limited (ASX: PME) shares are starting the week positively.

In morning trade, the ASX 200 tech stock is up 1% to $180.95, which is within a whisker of a new record high.

This latest gain means that the health imaging technology company's shares have now climbed almost 120% since this time last year.

Why are Pro Medicus shares rising again?

Investors have been bidding the company's shares higher on Monday for a couple of reasons.

One is a strong night of trade on Wall Street's tech-focused Nasdaq index on Friday which is giving ASX 200 tech stocks a nice boost on Monday. For example, the S&P/ASX All Technology Index is currently up 0.8% in early trade.

In addition, investors are buying Pro Medicus' shares this morning after responding positively to the release of another very positive announcement.

According to the release, Pro Medicus' wholly owned U.S. subsidiary, Visage Imaging Inc, has signed a major contract renewal with St Louis based Mercy Health.

The release reveals that Mercy Health has committed to an eight-year term. The contract has a minimum value of $98 million over the period.

Management advised that the deal, which covers both Visage 7 Viewer and Visage 7 Open Archive, is transaction-based and has been negotiated at a higher per transaction cost. The term of the renewal has also been increased to eight years from seven years as per the original contract.

The ASX 200 stock notes that its Visage 7 suite of products are the foundation of an ultra-fast, clinically rich, and highly scalable platform that can seamlessly be implemented in both public and private cloud environments.

The complements its leading suite of RIS, PACS, Artificial Intelligence (AI) and e-health solutions, which it believes constitutes one of the most comprehensive end-to-end offerings in healthcare imaging. And judging by the contract wins that Pro Medicus keeps reporting, this certainly appears to be the case.

'Unparalleled value'

The ASX 200 tech stock's CEO, Dr Sam Hupert, was pleased with the agreement. He believes it is a testament to the quality of its offering. Dr Hupert said:

The industry norm for renewals is for short extensions to the original contract at the same or lower price. The fact that Mercy has renewed for a longer contract term and at an increased price shows confidence in our offering and reinforces our belief that the Visage solution delivers unparalleled value in terms of both financial and clinical ROI.

Motley Fool contributor James Mickleboro has positions in Pro Medicus. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Pro Medicus. The Motley Fool Australia has recommended Pro Medicus. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Technology Shares

Man with rocket wings which have flames coming out of them.
Technology Shares

Guess which ASX All Ords share is rocketing 16% on an asset sale

This share is catching the eye with a very big gain on Friday. But why is it rising?

Read more »

a man clasps his hand to his forehead as he looks down at his phone and grimaces with a pained expression on his face as he watches the Pilbara Minerals share price continue to fall
Technology Shares

Why are Megaport shares sinking 14% on Friday?

Why are investors hitting the sell button? Let's find out.

Read more »

A white and black robot in the form of a human being stands in front of a green graphic holding a laptop and discussing robotics and automation ASX shares
Technology Shares

Why today is a big day for this ASX 200 AI stock

This company stands to benefit from 'one of the most profound transformations in the history of technology'.

Read more »

A man holds his head in his hands, despairing at the bad result he's reading on his computer.
Technology Shares

Why are WiseTech Global shares crashing almost 20% today?

Recent controversy has led to delays to an important launch and hit its revenues.

Read more »

Woman with speaker
Technology Shares

After falling 62%, this leading ASX 200 share could be gearing up for growth!

This industry-leading company looks like a turnaround opportunity to me.

Read more »

A man has computer-generated images rushing through his head indicating an AI (Artificial Intelligence) concept of a communication network.
Technology Shares

ASX investors are obsessed with Nvidia shares! Here's why

The global chipmaker reported a 94% increase in annual revenue in the third quarter.

Read more »

A woman sits at her computer with her hand to her mouth and a contemplative smile on her face as she reads about the performance of Allkem shares on her computer
Technology Shares

Own WiseTech shares? Here's what to watch at Friday's AGM

This could be one of the major events of the year.

Read more »

Woman and man calculating a dividend yield.
Technology Shares

This ASX tech stock is down 93% from its highs. Could Trump tariffs give it a boost?

The ASX tech stock could enjoy tailwinds from Trump’s threatened tariffs.

Read more »